362 related articles for article (PubMed ID: 17155854)
1. An update on pharmacological approaches to neurodegenerative diseases.
Scatena R; Martorana GE; Bottoni P; Botta G; Pastore P; Giardina B
Expert Opin Investig Drugs; 2007 Jan; 16(1):59-72. PubMed ID: 17155854
[TBL] [Abstract][Full Text] [Related]
2. New therapeutic strategy for Parkinson's and Alzheimer's disease.
Esposito E; Cuzzocrea S
Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
[TBL] [Abstract][Full Text] [Related]
3. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis modulators in the therapy of neurodegenerative diseases.
Deigner HP; Haberkorn U; Kinscherf R
Expert Opin Investig Drugs; 2000 Apr; 9(4):747-64. PubMed ID: 11060707
[TBL] [Abstract][Full Text] [Related]
5. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
8. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
[TBL] [Abstract][Full Text] [Related]
9. Rare Neurodegenerative Diseases: Clinical and Genetic Update.
Matilla-Dueñas A; Corral-Juan M; Rodríguez-Palmero Seuma A; Vilas D; Ispierto L; Morais S; Sequeiros J; Alonso I; Volpini V; Serrano-Munuera C; Pintos-Morell G; Álvarez R; Sánchez I
Adv Exp Med Biol; 2017; 1031():443-496. PubMed ID: 29214587
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
Islam MT
Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
[TBL] [Abstract][Full Text] [Related]
12. Curcuminoids in neurodegenerative diseases.
Kim DS; Kim JY; Han Y
Recent Pat CNS Drug Discov; 2012 Dec; 7(3):184-204. PubMed ID: 22742420
[TBL] [Abstract][Full Text] [Related]
13. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
Chen JF; Chern Y
Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
[TBL] [Abstract][Full Text] [Related]
14. Antiapoptotic drugs: a therapautic strategy for the prevention of neurodegenerative diseases.
Sureda FX; Junyent F; Verdaguer E; Auladell C; Pelegri C; Vilaplana J; Folch J; Canudas AM; Zarate CB; Pallès M; Camins A
Curr Pharm Des; 2011; 17(3):230-45. PubMed ID: 21348832
[TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders.
Naoi M; Maruyama W
Curr Pharm Des; 2010; 16(25):2799-817. PubMed ID: 20698822
[TBL] [Abstract][Full Text] [Related]
16. Neuronal apoptosis in neurodegenerative diseases: from basic research to clinical application.
Kermer P; Liman J; Weishaupt JH; Bähr M
Neurodegener Dis; 2004; 1(1):9-19. PubMed ID: 16908969
[TBL] [Abstract][Full Text] [Related]
17. Sigma-1 (σ
Maurice T; Goguadze N
Handb Exp Pharmacol; 2017; 244():81-108. PubMed ID: 28275911
[TBL] [Abstract][Full Text] [Related]
18. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Sonkusare SK; Kaul CL; Ramarao P
Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
[TBL] [Abstract][Full Text] [Related]
19. New pharmacologic horizons in the treatment of Parkinson disease.
Bonuccelli U; Del Dotto P
Neurology; 2006 Oct; 67(7 Suppl 2):S30-8. PubMed ID: 17030738
[TBL] [Abstract][Full Text] [Related]
20. Metal attenuating therapies in neurodegenerative disease.
Mot AI; Wedd AG; Sinclair L; Brown DR; Collins SJ; Brazier MW
Expert Rev Neurother; 2011 Dec; 11(12):1717-45. PubMed ID: 22091597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
